Induction of Pluripotent Protective Immunity Following Immunisation with a Chimeric Vaccine against Human Cytomegalovirus

Based on the life-time cost to the health care system, the Institute of Medicine has assigned the highest priority for a vaccine to control human cytomegalovirus (HCMV) disease in transplant patients and new born babies. In spite of numerous attempts successful licensure of a HCMV vaccine formulatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Jie, Rist, Michael, Cooper, Leanne, Smith, Corey, Khanna, Rajiv
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533118/
https://www.ncbi.nlm.nih.gov/pubmed/18806877
http://dx.doi.org/10.1371/journal.pone.0003256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2533118/
https://www.ncbi.nlm.nih.gov/pubmed/18806877
http://dx.doi.org/10.1371/journal.pone.0003256

Ejemplares similares